Activation and suppression of fibroblast function

Eye (Basingstoke)

Volumn 8, Issue 2, 1994, Pages 188-195

  Khaw, Peng T ^a,b,c   Occleston, N L ^a,c   Schultz, G ^b,c   Grierson, I ^a,d   Sherwood, M B ^b   Larkin, G ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antiproliferative agents; Fibroblast; Growth factors; RNA; Scarring; Wound healing

Indexed keywords

ANTERIOR EYE SEGMENT; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; EXTRACELLULAR MATRIX; FIBROBLAST; FILTERING OPERATION; GLAUCOMA; PERFORATING EYE INJURY; REVIEW; SCAR FORMATION; WOUND HEALING;

EID: 0028362632     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.1994.44     Document Type: Article

References (82)

1. Leske MC. The epidemiology of open-angle glaucoma. Am J Epidemiol 1983;118:166-91.
2. Foster A, Johnson GJ. Magnitude and causes of blindness in the developing world. lnt Ophthalmol 1990; 14:135-40.
3. Armaly MF, Krueger DE, Maunder L. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual field defects. Arch Ophthalmol 1980;98:2163-7.
4. Sommer A. Intraocular pressure and glaucoma [Editorial]. Am J Ophthalmol 1989;107:186-8.
5. Watson PG, Grierson I. The place of trabeculectomy in the treatment of glaucoma. Ophthalmology 1981;88:175-96.
6. Jay JL. Rational choice of therapy in primary open angle glaucoma. Eye 1992;6:243-7.
7. Jay JL, Allan D. The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease. Eye 1989;3:528-35.
8. Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol 1988;72:881-9.
9. Hitchings RA, Migdal CS, Wormald R, Poinooswamy D, Fitzke F. The primary treatment trial. The changes in the visual field analysis by computer-assisted perimetry. Eye 1994;8:117-20.
10. Lichter PR, Becker MH, Janz NK. The case for quality of life assessment in glaucoma clinical trials. In: Krieglstein GK, editor. Glaucoma update IV. Berlin: Springer, 1991:187-92.
11. Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 1990;108:1543-8.
12. Cairns JE. Trabeculectomy: preliminary report of a new method. Am J Ophthalmol 1968;66:673-9.
13. Benedikt OP. Drainage mechanism after filtration. Glaucoma 1979;1:71-7.
14. Miller MH, Rice NSC. Trabeculectomy combined with P radiation for congenital glaucoma. Br J Ophthalmol 1991;75:584-90.
15. Longstaff S, Wormald RPL, Mazover A, Hitchings RA. Glaucoma triple procedures: efficacy of intraocular pressure control and visual outcome. Ophthalmic Surg 1990; 21:786-93.
16. Inaba Z. Long term results of trabeculectomy in the Japanese: an analysis of life-table method. Jpn J Ophthalmol 1982;26: 361-73.
17. Heuer DK, Parrish RK II, Gressel MG, Anderson DR, Palmberg PF, Hodapp E, et al. Trabeculectomy in the aphakic eye. Ophthalmology 1984;91:1045-51.
18. Stewart RH, Kimbrough RL, Bachh H, Allbright M. Trabeculectomy and modifications of trabeculectomy. Ophthalmic Surg 1979;10:76-80.
19. Schwartz AL, Anderson DR. Trabecular surgery. Arch Ophthalmol 1974;92:134-8.
20. Sturmer J, Broadway DC, Hitchings RA. Young patient trabeculectomy: assessment of risk factors for failure. Ophthalmology 1993;100:928-39.
21. Miller RD, Barber JC. Trabeculectomy in black patients. Ophthalmic Surg 1981;12:46-50.
22. Berson D, Landau L, Zauberman H, Blumenthal M. Filtering operations in Africans. Am J Ophthalmol 1969;67:395-8.
23. Iliff CE. Surgical control of glaucoma in the Negro. Am J Ophthalmol1944;27:731-8.
24. Merritt JC. Filtering procedures in American blacks. Ophthalmic Surg 1980;11:91-4.
25. The fluorouracil filtering surgery study group. Fluorouracil filtering surgery study: one-year follow-up. Am J Ophthalmol 1989;108:625-35.
26. Heuer DK, Parrish RK II, Gressel MG, Hodapp E, Desjardins DC, Skuta GL, et al. 5-Fluorouracil and glaucoma filtering surgery. III. Intermediate follow-up of a pilot study. Ophthalmology 1986;93:1537-46.
27. Herschler J. The inhibitory factor in aqueous humour. Vision Res 1981;21:163.
28. Jampel HD. Ascorbic acid is cytotoxic to dividing human Tenon’s capsule fibroblasts: a possible contributing factor in glaucoma filtration surgery success. Arch Ophthalmol 1990; 108:1323-5.
29. Joseph JP, Grierson I, Hitchings RA. Normal rabbit aqueous humour, fibronectin and fibroblast conditioned medium are chemoattractant to Tenon’s capsule fibroblasts. Eye 1987;1:585-92.
30. Joseph JP, Grierson I, Hitchings RA. Chemotactic activity of aqueous humour: a cause of failure of trabeculectomies. Arch Ophthalmol 1989;107:69-74.
31. Krause U, Niemi A, Raunio A. Effect of paracentesis on the protein content of the aqueous humour. Ophthalmologica 1971;163:136-49.
32. Snaders DR, Kraff MC, Lieberman HL. Breakdown and re-establishment of the blood-aqueous barrier with implant surgery. Arch Ophthalmol 1982;100:588-92.
33. Reddan J, Weinsieder A, Wilson D. Aqueous humour from traumatised eyes triggers cell division in the epithelia of cultured cells. Exp Eye Res 1979;28:267-76.
34. Harris AK, Stopak D, Wild P. Fibroblast traction as a mechanism for collagen morphogenesis. Nature 1981; 290:249-51.
35. Ross R, Odland G. Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations and fibrogen-esis. J Cell Biol 1968;39:152-68.
36. Miller MH, Grierson I, Unger WI, Hitchings RA. Wound healing in an animal model of glaucoma fistulising surgery in the rabbit. Ophthalmic Surg 1989;20:350-7.
37. Regan EE Scleral cautery with iridectomy: an experimental study. Trans Am Ophthalmol Soc 1963;61:219-31.
38. Desjardins DC, Parish RK II, Folberg R, et al. Wound healing after filtering surgery in owl monkeys. Arch Ophthalmol 1986; 104: 1835-9.
39. Hitchings RA, Grierson I. Clinico-pathological correlation in eyes with failed fistulising surgery. Trans Ophthalmol Soc UK 1983;103:84-8.
40. Peacock E. Wound repair. Philadelphia: Saunders, 1984: 102-40.
41. Postlethwaite AE, Synderman RK, Kang AH. Generation of a fibroblast chemotactic factor in serum by activation of complement. J Clin Invest 1979;64:1379-85.
42. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987; 165:251-6.
43. Postlethwaite AE, Seyer JM, Kang Ah. Chemotactic attraction of human fibroblasts to type I-II-III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978;75:871-5.
44. Postlethewaite AE, Kang AH. Collagen and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med 1976;143:1299-307.
45. Postlethwaite AE, Keski-Oja J, Balian G. Induction of fibroblast chemotaxis by fibronectin: localisation of the chemotactic region to a 140 000 molecular weight nongelatin-binding fragment. J Exp Med 1981;153:494-9.
46. Albrink WS, Wallace AC. Aqueous humor as a tissue culture nutrient. Proc Soc Exp Biol Med 1951;77:754-8.
47. Shah M, Foreman DM, Ferguson MWJ. Control of scarringin adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992;339:213-4.
48. Joseph JP, Grierson I, Hitchings RA. Taxol, cytochalasin B and colchicine effects on fibroblast migration and contraction: a role in glaucoma filtration surgery. Curr Eye Res 1989;8:203-15.
49. Jampel HD, Leong KW, Koya P, Quigley HA. The use of hydrophobic drugs incorporated into polyanhydrides in experimental glaucoma surgery. Invest Ophthalmol Vis Sci (Suppl) 1990;31:2.
50. Siegel RC. Collagen cross-linking effect of D-penicillamine on cross-linking in vivo. J Biol Chern 1977;252:254.
51. Mc Guigan LJB, Cook DJ, Yablonski ME. Dexamethasone, D-penicillamine, and glaucoma filtering surgery in rabbits. Invest Ophthalmol Vis Sci 1986;27:1755.
52. Mc Guigan LJB, Mason RP, Sanchez R, Quigley HA. D-penicillamine and beta-aminopropionitrile effects on experimental filtering surgery. Invest Ophthalmol Vis Sci 1987;28: 1625-1629.
53. Moorhead LC, Stewart RH, Kimbrough PL, Gross RL, Cyrlin MN, Le Blanc RP, Shields MB, Kapetansky FN. Use of beta-aminopropionitrile following glaucoma filtering surgery. Invest Ophthalmol Vis Sci (Suppl) 1990;31:3.
54. Chen DM, DiSabato G, Field L, Gallo AA, Harshman S. Some immunological effects of penicillamine. Clin Exp Immunol 1977;30:317.
55. Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease: cell culture evaluation. Arch Ophthalmol 1984;102:598-604.
56. Blumenkranz MS, Ophir A, Claflin AJ, Hajek A. FluorouraciI for the treatment of massive periretinal proliferation. Am J OphthalmoI 1982;94:458-67.
57. Lee DA, Shapourifar-Tehrani D, Kitada S. The effect of 5-flu-orouracil and cytarabine on human fibroblasts from Tenon’s capsule. Invest ophthalmol Vis Sci 1990;31: 1848-55.
58. Litin BS, Herscler J. Silver staining of human aqueous humour proteins resolved by gel electrophoresis. Graefes Arch Clin Exp Ophthalmol 1984;221:290-2.
59. Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin-l, a potential regulator of fibroblast proliferation. J Immunol 1982;128:2177.
60. Lee DA, Shapourifar-Tehrani S, Stephenson TR, Kitada S. The effects of the fluorinated pyrimidines FUR, FUdR, FUMP, and FdUMP on human Tenon’s fibroblasts. Invest Ophthalmol Vis Sci 1991;32:2599-609.
61. Gillies M, Su T, Sarossy M, Hollows E Interferon-alpha 2b inhibits proliferation of human Tenon’s capsule fibroblasts. Graefes Arch Clin Exp Ophthalmol 1993;231:118-21.
62. Lee DA, Lee TC, Cortes AE, Kitada S. Effects of mithramy-cin, mitomycin, daunorubicin and bleomycin on human subconjunctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci 1990;31:2136-44.
63. Blumenkranz MS, Hartzer MK, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. II. Differing antiproliferative activity of the fluoropyrimidines. Arch Ophthalmol 1987;105:396-9.
64. Senderoff RI, Weber PA, Smith DR, Sokolski TD. Evaluation of antiproliferative agents using a cell culture model. Invest Ophthalmol Vis Sci 1990;31:2572-8.
65. Skuta GL, Assil K, Parrish RK II, Folberg R, Weinreb RN. Filtering surgery in owl monkeys treated with the antimetabolite 5-fluorouridine 5' -monophosphate entrapped in multi-vesicular liposomes [letter]. Am J Ophthalmol 1987; 103: 714-5.
66. Kay JS, Litin BS, Jones MA, Fryczkowski AW, Chvapil M, Herschler J. Delivery of antifibroblast agents as adjuncts to filtration surgery. II. Delivery of 5-fluorouracil and bleomycin in a collagen implant: pilot study in the rabbit. Ophthalmic Surg 1986;17:796-801.
67. Sachdev S, Zou X, Higginbotham E. The effect of 5-fluorou-racil impregnated collagen shield implants in filtration surgery. Invest Ophthalmol Vis Sci (Suppl) 1990;31:3.
68. Lee DA, Flores RA, Anderson PJ, Leong KW, Teekhasaenee C, De Kater AW, Hertzmark E. Glaucoma filtration surgery in rabbits using bioerodible polymers and 5-fluorouracil. Ophthalmology 1987;94:1523-30.
69. Jampel HD, Leong KW, Dunkelburger GR, Quigley HA. Glaucoma filtering surgery in monkeys using 5-fluorouridine in poly anhydride discs. Arch Ophthalmol 1990;108:430-5.
70. Winter DF, Jones MA, Simmons ST, Smith RS. A histologic analysis of 5-fluorouracil liposomal delivery system following subconjunctival injection in rabbits. Invest Ophthalmol Vis Sci (Suppl) 1987;28:271.
71. Chen C-W, Huang H-T, Bair JS, Lee C-C. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol 1990;6:175-82.
72. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia Pacif Acad Ophthalmol 1983;9:172-7.
73. Khaw PT, Sherwood MB, MacKay SLD, Rossi MJ, Schultz GS. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol 1992;110:1150-4.
74. Khaw PT, Ward S, Grierson I, Rice NSC. The effects of beta-radiation on proliferating human Tenon’s capsule fibroblasts. Br J Ophthalmol 1991;75:580-3.
75. Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NSC. The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon’s fibroblasts. Invest Ophthalmol Vis Sci 1992;33:2043-52.
76. Doyle JW, Sherwood MB, Khaw PT, McGorray S, Smith ME Effects of different regimens of 5-fluorouracil on experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci 1993;34:3313-9.
77. Khaw PT, Doyle JW, Sherwood MB, Smith FM, Mc Gorray S. Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology 1993;100:367-72.
78. Khaw PT, Doyle JW, Sherwood MB, Grierson I, Schultz GS, McGorray S. Prolonged localised tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 1993;111:263-7.
79. Khaw PT, Sherwood MB, Doyle JW, Smith MF, Grieson I, McGorray S, Schultz GS. Intraoperative and post-operative treatment with 5-fluorouracil and mitomycin-C: long term effects in vivo on subconjunctival and scleral fibroblasts. Int Ophthalmol 1992;16:381-5.
80. Khaw PT, Mannan M, Vyas W, Alexander R, Jefferies L, Sherwood MB, etal. Singleintraoperative exposures to mitomycin c (MMC): long term effects on scleral cellularity. Invest Ophthalmol Vis Sci (Suppl) 1993;34:726.
81. Sherwood MB, Grierson I, Millar L, Hitchings RA. Longterm morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon’s capsule in glaucomatous patients. Ophthalmology 1989;96:327-35.
82. Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 1992; 99:197-202.